---
figid: PMC3342058__fimmu-03-00036-g002
figlink: /pmc/articles/PMC3342058/figure/F2/
number: Figure 2
caption: Major therapeutic targets for inhibition of donor-reactive memory T cell
  responses. Transplantation therapeutics have been developed that target memory T
  cell costimulation pathways, intracellular signaling pathways, and trafficking molecules.
  Alemtuzumab, anti-CD52 monoclonal antibody. Alefacept, LFA-3 Ig fusion protein.
  Belatacept, high-affinity CTLA-4 Ig fusion protein. Anti-OX40L mAb, anti-OX40 ligand
  monoclonal antibody. Efalizumab, anti-LFA-1 monoclonal antibody. Natalizumab, anti-VLA-4
  monoclonal antibody. Sirolimus, Mammalian Target of Rapamycin (mTOR) pathway inhibitor.
  Tacrolimus, Calcineurin A (CnA)-NFAT pathway inhibitor. Oxelumab, anti-OX40 monoclonal
  antibody. Bortezomib, protease inhibitor. Gray box, FDA approved therapeutic. Blue
  box, experimental therapeutic under clinical development.
pmcid: PMC3342058
papertitle: 'Heterogeneity within T Cell Memory: Implications for Transplant Tolerance.'
reftext: Scott M. Krummey, et al. Front Immunol. 2012;3:36.
pmc_ranked_result_index: '103451'
pathway_score: 0.8089928
filename: fimmu-03-00036-g002.jpg
figtitle: Major therapeutic targets for inhibition of donor-reactive memory T cell
  responses
year: '2012'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3342058__fimmu-03-00036-g002.html
  '@type': Dataset
  description: Major therapeutic targets for inhibition of donor-reactive memory T
    cell responses. Transplantation therapeutics have been developed that target memory
    T cell costimulation pathways, intracellular signaling pathways, and trafficking
    molecules. Alemtuzumab, anti-CD52 monoclonal antibody. Alefacept, LFA-3 Ig fusion
    protein. Belatacept, high-affinity CTLA-4 Ig fusion protein. Anti-OX40L mAb, anti-OX40
    ligand monoclonal antibody. Efalizumab, anti-LFA-1 monoclonal antibody. Natalizumab,
    anti-VLA-4 monoclonal antibody. Sirolimus, Mammalian Target of Rapamycin (mTOR)
    pathway inhibitor. Tacrolimus, Calcineurin A (CnA)-NFAT pathway inhibitor. Oxelumab,
    anti-OX40 monoclonal antibody. Bortezomib, protease inhibitor. Gray box, FDA approved
    therapeutic. Blue box, experimental therapeutic under clinical development.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ICOS
  - CD86
  - MTOR
  - CD28
  - TNFSF4
  - CD58
  - CTLA4
  - NFKB1
  - CD52
  - TNFRSF4
  - CD80
  - RELB
  - NFKB2
  - CD27
  - ICOSLG
  - CD70
  - RELA
  - REL
  - Tacrolimus
  - Sirolimus
genes:
- word: ICos
  symbol: ICOS
  source: hgnc_symbol
  hgnc_symbol: ICOS
  entrez: '29851'
- word: CD86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: OX40L
  symbol: OX-40L
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF4
  entrez: '7292'
- word: LFA-3
  symbol: LFA3
  source: hgnc_prev_symbol
  hgnc_symbol: CD58
  entrez: '965'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: CD52
  symbol: CD52
  source: hgnc_symbol
  hgnc_symbol: CD52
  entrez: '1043'
- word: OX40
  symbol: OX40
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF4
  entrez: '7293'
- word: CD80
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: CD27
  symbol: CD27
  source: hgnc_symbol
  hgnc_symbol: CD27
  entrez: '939'
- word: ICOSL
  symbol: ICOS-L
  source: hgnc_alias_symbol
  hgnc_symbol: ICOSLG
  entrez: '23308'
- word: CD70
  symbol: CD70
  source: hgnc_symbol
  hgnc_symbol: CD70
  entrez: '970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
chemicals:
- word: Tacrolimus
  source: MESH
  identifier: D016559
- word: Sirolimus
  source: MESH
  identifier: D020123
diseases: []
---
